what are the risks of glp-1 Your guide to side effects π¨ As GLP-1 Use Explodes,
Description
GLP-2 (Tirzepatide) is a dual incretin receptor agonist widely utilized in preclinical research involving metabolic regulation, incretin signaling, and energy balance-associated biochemical pathways
$LLY -0.60% today as Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes More Info:

When B12 intake is already compromised by reduced food consumption on GLP-1, using the form that requires the fewest conversion steps makes sense

Heres how to interpret hydrogen and methane breath tests in patients using GLP-1 therapy.
Dairy-free, gluten-free, and soy-free